Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-26 @ 3:20 AM
Study NCT ID:
NCT00295620
Status:
COMPLETED
Last Update Posted:
2019-10-02
First Post:
2006-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Secondary Adjuvant Long Term Study With Arimidex
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-23
First Submit QC Date:
None
Study First Post Date:
2006-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-14
Results First Submit QC Date:
None
Results First Post Date:
2019-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-01
Last Update Post Date:
2019-10-02
Last Update Post Date Type:
ACTUAL